Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 24, 2007Antimicrobial Agents and ChemotherapyOpen Access

Global Challenge of Multidrug-ResistantAcinetobacter baumannii

View Full Paper
Ask AI
Bookmark
Share

Authors

FPFederico PérezGeriatric Research Education and Clinical CenterAHAndrea M. HujerLouis Stokes Cleveland VA Medical CenterKHKristine M. HujerUnited States Department of Veterans Affairs

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pérez et al. (2007) studied this question.

synapsesocial.com/papers/6a0c11abc63d985fc0884cd8https://doi.org/10.1128/aac.01464-06
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heteroresistance to Colistin in Multidrug-Resistant <i>Acinetobacter baumannii</i>2006 · 555 citations
  2. 2OXA β-lactamases in Acinetobacter: the story so far2005 · 192 citations
  3. 3Challenges in Identifying New Antimicrobial Agents Effective for Treating Infections with Acinetobacter baumannii and Pseudomonas aeruginosa2006 · 174 citations
  4. 4Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant <i>Acinetobacter baumannii</i>2002 · 145 citations
  5. 5Reliability of the E-Test Method for Detection of Colistin Resistance in Clinical Isolates of <i>Acinetobacter baumannii</i>2005 · 127 citations